fbpx

Healius Ltd

HLS.AX

$0.91

Closing

▲1.08%

1D

▼-14.07%

YTD

HLS

BBG001S5SNJ4

Exchange

Sector

Market cap

$655.70M

Volume

1,065,402

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$655.70M

Analysts' Rating

SELL

Price Target (Mean)

1.07

Total Analysts

4

P/E

Operating Margin

2.71%

Beta

1.10

Revenue Growth

6.45%

52 week high

$1.20

52 week low

$0.70

Div. Yield

0.00%

EPS Growth

-98.56

Company Profile

Healius Limited is a healthcare company. The Company’s segments include Pathology, Imaging and Other. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment provides imaging services from standalone imaging sites, hospitals and medical centers. It has a network of pathology laboratories, collection centers and diagnostic imaging centers. It provides specialty diagnostic services to consumers and their referring practitioners. Its brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. Its Pathology operates 100 medical laboratories and 2,000 patient collection centers across metropolitan, regional and remote Australia. IQ Pathology is a specialized dermatopathology laboratory that provides comprehensive dermatopathology services Australia wide.